3 Dividend Stocks Worth Buying Now?
Thanks to surging stock prices over the past two years, dividend yields on major stock indices have fallen to fairly low levels. The S&P 500, for instance, currently carries an average yield of just 1.3%.
The mature companies in the Dow Jones Industrial Average fare a bit better, and some of them offer yields that exceed the S&P 500 several times over. » Read more about: 3 Dividend Stocks Worth Buying Now? »
Read More
Market Commentary: 1 Extraordinary Firm Soaring Right Now
It’s bad out there the news media will tell you. Silicon Valley Bank collapsed. First Republic Bank collapsed. First Horizon shares crashed. Bank PacWest cratered. US Bancorp tumbled.
Read More
Alert: 1 AI Stock To Hold For The Next 10 Years
Investment Alert: Buy Google (GOOGL) Under $110/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
When ChatGPT launched, it became the fastest growing product,
» Read more about: Alert: 1 AI Stock To Hold For The Next 10 Years »
Read More
Market Commentary: 1 Stock Buffett Did NOT Sell Has 5x Growth
Perhaps the most anticipated 13F filing of all is from Berkshire Hathaway. Investors muse: What did Buffett just buy? What did Berkshire Hathaway sell?
Read More
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
2 Stocks Set To 2x In 24 Months
It’s been a volatile stretch for the markets. Between trade tensions, economic jitters, and mixed signals from policymakers, investors have had no shortage of reasons to stay on edge. The S&P 500 has slipped into correction territory, down more than 10% from its highs thanks in part to uncertainty over tariffs and recession fears.
But for seasoned investors,
» Read more about: 2 Stocks Set To 2x In 24 Months »
Read MoreThe Spotlight
1 Dividend Aristocrat To Be Wary Of
Residential real estate investment trust (REIT) Essex Property Trust, Inc. (NYSE:ESS) operates in West Coast markets, primarily acquiring, developing, and managing multifamily residential properties. It has a portfolio of more than 60,000 apartment units, primarily located in California and Seattle.
Founded in 1971 and going public in 1994,
» Read more about: 1 Dividend Aristocrat To Be Wary Of »
Read MoreThe Daily
7 Ways Retirees Are Wasting Their Social Security Checks
Receiving Social Security benefits each month is vitally important for American retirees living on a fixed income.
» Read more about: 7 Ways Retirees Are Wasting Their Social Security Checks »